Cargando…

The Thomsen-Friedenreich Antigen: A Highly Sensitive and Specific Predictor of Microsatellite Instability in Gastric Cancer

Microsatellite instability (MSI) is a distinct molecular subtype of gastric cancer. In recent years, the clinical consequences of MSI and the therapeutic opportunities to target this peculiar cancer subtype became evident. However, despite the importance of MSI for the stratification of patients, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mereiter, Stefan, Polom, Karol, Williams, Coralie, Polonia, Antonio, Guergova-Kuras, Mariana, Karlsson, Niclas G., Roviello, Franco, Magalhães, Ana, Reis, Celso A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162870/ https://www.ncbi.nlm.nih.gov/pubmed/30189652 http://dx.doi.org/10.3390/jcm7090256

Ejemplares similares

Expression of Thomsen–Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability
por: Leão, Beatriz, et al.
Publicado: (2021)

The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule.
por: Dippold, W, et al.
Publicado: (1990)

Interaction of the Oncofetal Thomsen–Friedenreich Antigen with Galectins in Cancer Progression and Metastasis
por: Sindrewicz, Paulina, et al.
Publicado: (2016)

The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer
por: Kurtenkov, Oleg, et al.
Publicado: (2018)

Structural Basis for Distinct Binding Properties of the Human Galectins to Thomsen-Friedenreich Antigen
por: Bian, Cheng-Feng, et al.
Publicado: (2011)

A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer
por: Shen, Qiujin, et al.
Publicado: (2019)

Contribution of Thomsen-Friedenreich antigens to bladder cancer malignancy: Characterization of cell line models
por: Severino, Paulo F, et al.
Publicado: (2010)

A One-Step Chemoenzymatic Labeling Strategy for Probing Sialylated Thomsen–Friedenreich Antigen
por: Wen, Liuqing, et al.
Publicado: (2018)

Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
por: Kurtenkov, Oleg
Publicado: (2020)

Synthesis of the Thomsen-Friedenreich-antigen (TF-antigen) and binding of Galectin-3 to TF-antigen presenting neo-glycoproteins
por: Hoffmann, Marius, et al.
Publicado: (2020)

Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate
por: Kleski, Kristopher A., et al.
Publicado: (2020)

Exposure of Thomsen-Friedenreich Antigen on the Renal Tubules of a Patient with Capnocytophaga Infection-induced Acute Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2021)

Determination of thermodynamic parameters of Xerocomus chrysenteron lectin interactions with N-acetylgalactosamine and Thomsen-Friedenreich antigen by isothermal titration calorimetry
por: Damian, Luminita, et al.
Publicado: (2005)

Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer
por: Kurtenkov, Oleg, et al.
Publicado: (2015)

Glycoamino Acid Analogues of the Thomsen–Friedenreich Tumor-Associated Carbohydrate Antigen: Synthesis and Evaluation of Novel Antiproliferative Factor Glycopeptides
por: Siddiqui, Maqbool A., et al.
Publicado: (2017)

Isolipoic acid-linked gold nanoparticles bearing the thomsen friedenreich tumor-associated carbohydrate antigen: Stability and in vitro studies
por: Mondal, Utpal K., et al.
Publicado: (2022)

Evaluation of a novel fluorescent nanobeacon for targeted imaging of Thomsen-Friedenreich associated colorectal cancer
por: Nakase, Hiroshi, et al.
Publicado: (2017)

Increased Sialylation of Anti-Thomsen-Friedenreich Antigen (CD176) Antibodies in Patients with Gastric Cancer: A Diagnostic and Prognostic Potential
por: Kurtenkov, Oleg, et al.
Publicado: (2014)

The Potential Action of Thomsen–Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer
por: Peng, Ying, et al.
Publicado: (2020)

Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance
por: Kurtenkov, Oleg, et al.
Publicado: (2017)

Identification and Targeting of Thomsen–Friedenreich and IL1RAP Antigens on Chronic Myeloid Leukemia Stem Cells Using Bi-Specific Antibodies
por: Eldesouki, Raghda E, et al.
Publicado: (2021)

CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
por: Dragon, Anna Christina, et al.
Publicado: (2023)

Preclinical Analysis of JAA-F11, a Specific Anti–Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging
por: Karacosta, Loukia G., et al.
Publicado: (2018)

Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis
por: Tati, Swetha, et al.
Publicado: (2017)

Cell surface Thomsen-Friedenreich proteome profiling of metastatic prostate cancer cells reveals potential link with cancer stem cell-like phenotype
por: Li, Feng, et al.
Publicado: (2017)

Synthesis and biological evaluation of a novel MUC1 glycopeptide conjugate vaccine candidate comprising a 4’-deoxy-4’-fluoro-Thomsen–Friedenreich epitope
por: Johannes, Manuel, et al.
Publicado: (2015)

Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733]
por: Tati, Swetha, et al.
Publicado: (2017)

Thomsen and myotonia congenita.
por: Johnson, J
Publicado: (1968)

Myotonia Congenita. Thomsen's Disease
por: Variava, N. S.
Publicado: (1949)

Myotonia Congenita (Thomsen's Disease)
por: Chand, Amir, et al.
Publicado: (1945)

Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models
por: Ghazal, Diala, et al.
Publicado: (2022)

A New Neurosis. (Thomsen's Disease)
por: Spencer, William H.
Publicado: (1884)

Thomsen’s Disease—A Family History
por: Clemesha, J. C.
Publicado: (1897)

Sample handling of gastric tissue and O-glycan alterations in paired gastric cancer and non-tumorigenic tissues
por: Adamczyk, Barbara, et al.
Publicado: (2018)

Correction to Boeg Thomsen et al. (2021)
Publicado: (2022)

Complete Mesogastric Excisions Involving Anatomically Based Concepts and Embryological-Based Surgeries: Current Knowledge and Future Challenges
por: Girnyi, Sergii, et al.
Publicado: (2021)

Editorial: Microsatellite and microsatellite instability
por: How-Kit, Alexandre, et al.
Publicado: (2023)

MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy
por: Rodriquenz, Maria Grazia, et al.
Publicado: (2020)

Methylene Blue—Current Knowledge, Fluorescent Properties, and Its Future Use
por: Cwalinski, Tomasz, et al.
Publicado: (2020)

Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau
por: Starbuck, Kristen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_48ej2u3e3irmsef2g1tg081h12